Fig. 5: Postoperative ctDNA MRD detection and prognosis of TNBC patients. | Nature Communications

Fig. 5: Postoperative ctDNA MRD detection and prognosis of TNBC patients.

From: Dynamic ctDNA tracking stratifies relapse risk for triple negative breast cancer patients receiving neoadjuvant chemotherapy

Fig. 5: Postoperative ctDNA MRD detection and prognosis of TNBC patients.The alternative text for this image may have been generated using AI.

Kaplan–Meier analysis of EFS (A) and DRFS (B) stratified by longitudinal ctDNA MRD status in 82 patients. C Swimming plot showing the MRD test history of all 15 patients with recurrence. Survival analyses were performed using the Kaplan–Meier method. p values were calculated using the log-rank test. Hazard ratios (HR) and the corresponding confidence intervals (CI) were calculated using the Cox regression models. MRD micro residual disease. Source data are provided as a Source Data file.

Back to article page